Susanne Halken, MDa, Arne Høst, MD, DMScb, Ulla Niklassen, MDc, Lars G

Slides:



Advertisements
Similar presentations
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
Advertisements

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor.
House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: A possible delay in the manifestation of.
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma  Makoto Hoshino, MDa, Yutaka Nakamura, MDa,
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Badrul A. Chowdhury, MD, PhD 
NAEPP Expert Panel Report
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis  Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,
Mark T. S. Chan, MDa, Donald Y. M. Leung, MD, PhDb, Stanley J
Elephantiasis nostras: A case report
Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial  William Busse, MDa,
The impact of allergic rhinitis on bronchial asthma
Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with.
Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner,
Peter M. Wolfgram, MD, David B. Allen, MD 
Side effects of inhaled corticosteroids
Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid–dependent, persistent asthma  Gail.
Measurement of airborne mite allergen exposure in individual subjects
Increased sensitivity to bradykinin among African Americans
Reply Journal of Allergy and Clinical Immunology
Paul M. O’Byrne, MB, FRCPI, FRCP(C)a, Soren Pedersen, MD, PhDb 
A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations  John H. Toogood, MD,
A review of the current guidelines for allergic rhinitis and asthma
Physician-targeted program on inhaled therapy for childhood asthma
Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge  Adriaan.
News & Notes Journal of Allergy and Clinical Immunology
James P. Kemp, MDa, David A. Cook, MDb, Gary A
Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization  Qutayba Hamid, MD, PhD, Editor  Journal.
Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.
Wine-induced asthma: A placebo-controlled assessment of its pathogenesis  Hassan Vally, BSc (Hons), Amanda Carr, BAppSc, Jacque El-Saleh, RN, Philip Thompson,
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma  Mamert Milewski, MD, Lucyna Mastalerz, MD, Ewa Niżankowska, MD, Andrzej.
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)  Christian Möller, MD, PhDa, Sten.
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma  William.
Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms  Aaron M. Levy, MDa, Hirohito Kita, MDb, Sidney F. Phillips, MDa, Paul.
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Vascular endothelial growth factor in patients with acute asthma
A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma  Gordon D. Raphael, MDa, Robert.
News & Notes Journal of Allergy and Clinical Immunology
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma  Eugene R. Bleecker, MDa, Michael J. Welch, MDb,
Occupational asthma caused by sarsaparilla root dust
Omalizumab improves asthma-related quality of life in patients with severe allergic asthma  Albert Finn, MDa, Gary Gross, MDb, Julius van Bavel, MDc,
Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: A prospective study for 18 months  Wei Qing Wang, MB, Mary Sau Man.
A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein.
The 30th anniversary of the American Board of Allergy and Immunology: Then and now  Lynn Des Prez a, Charles E. Reed, MD, Lawrence B. Schwartz, MDb, John.
Gail G. Shapiro, MDa, Timothy G
Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled.
Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L
Inhaled β2 -agonists and airway responses to allergen
Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma  James P.
Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway.
Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy  Diane J. Pincus, MD, Teresa R. Humeston,
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Effect of continuing or finishing high-level sports on airway inflammation, bronchial hyperresponsiveness, and asthma: A 5-year prospective follow-up.
Larry C. Borish, MDa, Harold S
Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma  Stanley J. Szefler, MD, Lars-Goran Carlsson,
Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression 
The preventive effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children  Elio Novembre, MD, Gianfranco.
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial  Eli O. Meltzer, MDa,
News & Notes Journal of Allergy and Clinical Immunology
Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo- controlled study  Lone Nielsen, MD, Claus R. Johnsen, MD, Holger.
Presentation transcript:

Effect of mattress and pillow encasings on children with asthma and house dust mite allergy  Susanne Halken, MDa, Arne Høst, MD, DMScb, Ulla Niklassen, MDc, Lars G. Hansen, MDd, Frank Nielsen, MDa, Søren Pedersen, MD, DMScc, Ole Østerballe, MD, DMScd, Chris Veggerby, MSce, Lars K. Poulsen, DMSce  Journal of Allergy and Clinical Immunology  Volume 111, Issue 1, Pages 169-176 (January 2003) DOI: 10.1067/mai.2003.5 Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 1 Flowchart. BPT, Bronchial provocation test; asthma diary, diary with registration of peak flow, symptoms, and asthma medication during a 2-week period. Journal of Allergy and Clinical Immunology 2003 111, 169-176DOI: (10.1067/mai.2003.5) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 2 Flow diagram of the progress through the study. (a) Three subjects moved to another region, 2 before they received the encasings; (b) insufficient data concerning asthma medication and lack of dust samples; (c) concomitant treatment with unallowed medication (growth hormone). Journal of Allergy and Clinical Immunology 2003 111, 169-176DOI: (10.1067/mai.2003.5) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 3 Change in need for inhaled steroids. Daily dose of inhaled steroid (in micrograms) by the end of the study (y-axis) as a function of initial dose (x-axis) in children in the active treatment (filled circles) and placebo (open circles) groups is shown. Results are expressed as individual data points. Journal of Allergy and Clinical Immunology 2003 111, 169-176DOI: (10.1067/mai.2003.5) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 4 Change in need for inhaled steroids. Change from baseline in daily dose of inhaled steroid (in micrograms) by the end of the study in the active treatment (filled circles) and placebo (open circles) groups is shown. Results are expressed as individual data points, and P values for differences between medians are calculated by means of the Kruskal-Wallis test. Journal of Allergy and Clinical Immunology 2003 111, 169-176DOI: (10.1067/mai.2003.5) Copyright © 2003 Mosby, Inc. Terms and Conditions